Heavy chain-only antibodies with a stabilized human VH in transgenic chickens for therapeutic antibody discovery Admin / September 24, 2024 Heavy chain-only antibodies with a stabilized human VH in transgenic chickens for therapeutic antibody discovery Read More »
Chickens with a Truncated Light Chain Transgene Express Single-Domain H Chain-Only Antibodies admin / June 1, 2024 Chickens with a Truncated Light Chain Transgene Express Single-Domain H Chain-Only Antibodies Read More »
Deep Screening in Harmony with AI for Bispecific Antibody Discovery Admin / May 15, 2024 Deep Screening in Harmony with AI for Bispecific Antibody Discovery Read More »
Wrangling Diverse OmniAb Antibody Repertoires with OmniDeep Admin / December 15, 2023 Wrangling Diverse OmniAb Antibody Repertoires with OmniDeep Read More »
OmnidAb: Heavy Chain-Only Transgenic Chickens Produce Human Antibodies with Robust Immune Repertoires and High-Affinity Binding Admin / December 14, 2023 OmnidAb: Heavy Chain-Only Transgenic Chickens Produce Human Antibodies with Robust Immune Repertoires and High-Affinity Binding Read More »
Heavy Chain-Only Transgenic Chickens Produce Human Antibodies with Robust Immune Repertoires and High-Affinity Binding Admin / November 15, 2023 Heavy Chain-Only Transgenic Chickens Produce Human Antibodies with Robust Immune Repertoires and High-Affinity Binding Read More »
Wrangling Diverse OmniAb Antibody Repertoires with OmniDeep™ Admin / May 17, 2023 Wrangling Diverse OmniAb Antibody Repertoires with OmniDeep™ Read More »
Opening the Barn Door to Antibody Discovery admin / December 6, 2022 Opening the Barn Door to Antibody Discovery Read More »
High-Specificity OmniAb Antibodies for Bispecific Applications; 2022 World Bispecific Conference admin / September 21, 2022 High-Specificity OmniAb Antibodies for Bispecific Applications; 2022 World Bispecific Conference Read More »
Nucleic acid delivery of immune-focused SARS-CoV-2 nanoparticles drive rapid and potent immunogenicity capable of single-dose protection admin / January 12, 2022 Nucleic acid delivery of immune-focused SARS-CoV-2 nanoparticles drive rapid and potent immunogenicity capable of single-dose protection Read More »
